Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse
Currently, the treatment of pediatric high-grade osteosarcomas systematically includes one topoisomerase IIα inhibitor. This chemotherapy is usually adapted to the response to the neo-adjuvant therapy after surgery. The current and unique marker of chemoresponsiveness is the percentage of viable res...
Main Authors: | , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730327/ |